German Mail Service Stops Using Domestic Flights to Transport Letters after Nearly 63 Years

WISAG employees load a Eurowings Airbus A320-214 bound for Stuttgart with plastic boxes full of mail, at Berlin Brandenburg Airport, in Schönefeld, Germany, Thursday, March 28, 2024. (Soeren Stache/dpa via AP)
WISAG employees load a Eurowings Airbus A320-214 bound for Stuttgart with plastic boxes full of mail, at Berlin Brandenburg Airport, in Schönefeld, Germany, Thursday, March 28, 2024. (Soeren Stache/dpa via AP)
TT

German Mail Service Stops Using Domestic Flights to Transport Letters after Nearly 63 Years

WISAG employees load a Eurowings Airbus A320-214 bound for Stuttgart with plastic boxes full of mail, at Berlin Brandenburg Airport, in Schönefeld, Germany, Thursday, March 28, 2024. (Soeren Stache/dpa via AP)
WISAG employees load a Eurowings Airbus A320-214 bound for Stuttgart with plastic boxes full of mail, at Berlin Brandenburg Airport, in Schönefeld, Germany, Thursday, March 28, 2024. (Soeren Stache/dpa via AP)

Germany's main national postal carrier on Thursday stopped using domestic flights to transport letters after nearly 63 years, a move that reflects the declining significance of letter mail and allows it to improve its climate footprint.
Deutsche Post said the last planes carrying letters between northern and southern Germany, operated by Lufthansa unit Eurowings and Tui Fly, flew overnight on the Stuttgart-Berlin, Hannover-Munich and Hannover-Stuttgart routes, the Associated Press said.
The company said letters between those destinations will now be transported by road, allowing the company to reduce transport-related carbon dioxide emissions on the routes by over 80%.
“In times of climate change, airmail for domestic letters within Germany can no longer be justified — also because there is no longer the same urgency associated with letter mail as in decades past,” Marc Hitschfeld, chief operations officer of parent company DHL Group's German mail and parcel division, said in a statement.
Draft legislation approved by the German Cabinet in December, which still needs parliamentary approval, is set to reduce pressure on Deutsche Post to deliver letters quickly, allowing it to cut costs.
At present, the mail service is supposed to deliver at least 80% of letters on the working day after they are mailed. Under the planned new rules, it will have to deliver 95% by the third working day.
German domestic mail flights started in September 1961. Both the volume of mail carried by air and the number of destinations served have declined drastically since the mid-1990s.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”